• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型III类抗心律失常药物NIP-142对犬心房颤动和扑动的影响。

Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter.

作者信息

Nagasawa Hidehiko, Fujiki Akira, Fujikura Naoki, Matsuda Tomoyuki, Yamashita Toru, Inoue Hiroshi

机构信息

The Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.

出版信息

Circ J. 2002 Feb;66(2):185-91. doi: 10.1253/circj.66.185.

DOI:10.1253/circj.66.185
PMID:11999646
Abstract

The effects of a new benzopyran derivative, NIP-142, on atrial fibrillation (AF) and flutter (AFL) and on electrophysiological variables were studied in the dog. NIP-142 (3mg/kg) was administered intravenously to pentobarbital-anesthetized beagles during vagally-induced AF and during AFL induced after placement of an intercaval crush. Isolated canine atrial tissues were studied using standard microelectrode technique. NIP-142 terminated AF in 5 of 6 dogs after an increase in fibrillation cycle length (CL) and prevented reinitiation of AF in all 6 dogs. NIP-142 terminated AFL in all 6 dogs without any appreciable change in flutter CL, and prevented reinitiation of AFL in all 6 dogs. NIP-142 prolonged atrial effective refractory periods (11+/-5%, 3+/-3%, 12+/-3%, and 10+/-5% from the baseline value at basic CLs of 150, 200, 300, and 350ms, respectively) without changes in intraatrial conduction time. The prolongation of the atrial effective refractory period was greater in the presence of vagal stimulation. NIP-142 decreased action potential phase-1 notch and increased phase-2 plateau height without making any changes in the action potential duration, although it did reverse carbachol-induced shortening of the action potential duration. In conclusion, NIP-142 is effective in treating AFL and vagally-induced AF by prolonging atrial refractoriness.

摘要

在犬类动物中研究了一种新型苯并吡喃衍生物NIP - 142对心房颤动(AF)和心房扑动(AFL)以及电生理变量的影响。在戊巴比妥麻醉的比格犬诱发迷走神经介导的AF期间以及在腔静脉间挤压后诱发AFL期间,静脉注射NIP - 142(3mg/kg)。使用标准微电极技术研究离体犬心房组织。NIP - 142使6只犬中的5只在颤动周期长度(CL)增加后终止AF,并防止所有6只犬再次发生AF。NIP - 142使所有6只犬的AFL终止,扑动CL无明显变化,并防止所有6只犬再次发生AFL。NIP - 142延长心房有效不应期(在基础CL分别为150、200、300和350ms时,相对于基线值分别延长11±5%、3±3%、12±3%和10±5%),而心房内传导时间无变化。在迷走神经刺激存在的情况下,心房有效不应期的延长更大。NIP - 142降低动作电位1期切迹并增加2期平台高度,而动作电位持续时间无任何变化,尽管它确实逆转了卡巴胆碱诱导的动作电位持续时间缩短。总之,NIP - 142通过延长心房不应期有效治疗AFL和迷走神经介导的AF。

相似文献

1
Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter.新型III类抗心律失常药物NIP-142对犬心房颤动和扑动的影响。
Circ J. 2002 Feb;66(2):185-91. doi: 10.1253/circj.66.185.
2
A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation.一种用于治疗心房颤动的多离子通道阻滞剂NIP-142。
Cardiovasc Drug Rev. 2007 Winter;25(4):342-56. doi: 10.1111/j.1527-3466.2007.00025.x.
3
Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.在人类心房扑动和颤动期间静脉注射伊布利特与普鲁卡因胺的抗心律失常作用比较:转换疗效增强的电生理决定因素。
Circulation. 1997 Dec 16;96(12):4298-306. doi: 10.1161/01.cir.96.12.4298.
4
Ranolazine terminates atrial flutter and fibrillation in a canine model.雷诺嗪可终止犬模型中的心房扑动和心房颤动。
Heart Rhythm. 2014 Sep;11(9):1592-9. doi: 10.1016/j.hrthm.2014.05.038. Epub 2014 Jun 2.
5
Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model.K201的代谢物M-II终止心房扑动和颤动:犬无菌性心包炎模型研究
J Cardiovasc Pharmacol. 2015 May;65(5):494-9. doi: 10.1097/FJC.0000000000000219.
6
The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.缝隙连接调节剂GAP-134[(2S,4R)-1-(2-氨基乙酰基)-4-苯甲酰胺基吡咯烷-2-羧酸]可改善犬无菌性心包炎模型的传导并减少心房颤动/扑动。
J Pharmacol Exp Ther. 2009 Jun;329(3):1127-33. doi: 10.1124/jpet.108.150102. Epub 2009 Feb 27.
7
Electrophysiologic and antiarrhythmic effects of the new class III antiarrhythmic drug KCB-328 in experimental canine atrial flutter.新型III类抗心律失常药物KCB-328对实验性犬心房扑动的电生理及抗心律失常作用
J Cardiovasc Pharmacol Ther. 2001 Jul;6(3):297-306. doi: 10.1177/107424840100600310.
8
Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.新型IKACh阻滞剂NIP-151的体内和体外电生理及抗心律失常作用的表征:与IKr阻滞剂多非利特的比较
J Cardiovasc Pharmacol. 2008 Feb;51(2):162-9. doi: 10.1097/FJC.0b013e31815e854c.
9
Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.Azd7009:一种主要作用于心房的新型抗心律失常药物可有效终止并预防无菌性心包炎模型中的心房颤动和扑动再发。
J Cardiovasc Electrophysiol. 2004 Dec;15(12):1444-50. doi: 10.1046/j.1540-8167.2004.04354.x.
10
Acute intravenous conversion of canine atrial flutter: comparison of antiarrhythmic agents.犬心房扑动的急性静脉内转复:抗心律失常药物的比较
J Cardiovasc Pharmacol. 1995 Apr;25(4):539-44. doi: 10.1097/00005344-199504000-00005.

引用本文的文献

1
Characterization of VU0468554, a New Selective Inhibitor of Cardiac G Protein-Gated Inwardly Rectifying K Channels.VU0468554 是一种新型选择性心脏 G 蛋白门控内向整流钾通道抑制剂的特性研究。
Mol Pharmacol. 2021 Dec;100(6):540-547. doi: 10.1124/molpharm.121.000311. Epub 2021 Sep 9.
2
A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels.具有抗心律失常活性的苯并吡喃是含有 Kir3.1 的钾通道抑制剂。
J Biol Chem. 2021 Jan-Jun;296:100535. doi: 10.1016/j.jbc.2021.100535. Epub 2021 Mar 11.
3
Mechanisms of termination and prevention of atrial fibrillation by drug therapy.
药物治疗终止和预防心房颤动的机制。
Pharmacol Ther. 2011 Aug;131(2):221-41. doi: 10.1016/j.pharmthera.2011.02.002. Epub 2011 Feb 18.
4
Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.心房抗心律失常药物AVE0118对心脏离子通道的作用
Naunyn Schmiedebergs Arch Pharmacol. 2004 Sep;370(3):183-92. doi: 10.1007/s00210-004-0957-y. Epub 2004 Aug 31.